(Q43566406)

24 November 2017

title

The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children (English)

1 reference

24 November 2017

1 reference

Nuhoğlu Y

1

1 reference

24 November 2017

Bahçeciler NN

series ordinal

2

1 reference

24 November 2017

Barlan IB

series ordinal

3

1 reference

24 November 2017

Müjdat Başaran M

series ordinal

4

1 reference

24 November 2017

publication date

1 March 2001

1 reference

Annals of Allergy, Asthma & Immunology

24 November 2017

published in

1 reference

24 November 2017

volume

86

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

318-322

1 reference

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Inhaled flunisolide for acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

Bioequivalent doses of budesonide and prednisone in moderate and severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963306-6

7 January 2021

10.1016/S1081-1206(10)63306-6

Identifiers

DOI

1 reference

24 November 2017

1 reference